Splicing factor BUD31 promotes ovarian cancer progression through sustaining the expression of anti-apoptotic BCL2L12

Dysregulated expression of splicing factors has important roles in cancer development and progression. However, it remains a challenge to identify the cancer-specific splicing variants. Here we demonstrate that spliceosome component BUD31 is increased in ovarian cancer, and its higher expression pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zixiang, Wang, Shourong, Qin, Junchao, Zhang, Xiyu, Lu, Gang, Liu, Hongbin, Guo, Haiyang, Wu, Ligang, Shender, Victoria O., Shao, Changshun, Kong, Beihua, Liu, Zhaojian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587234/
https://www.ncbi.nlm.nih.gov/pubmed/36271053
http://dx.doi.org/10.1038/s41467-022-34042-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587234/
https://www.ncbi.nlm.nih.gov/pubmed/36271053
http://dx.doi.org/10.1038/s41467-022-34042-w

Ejemplares similares